Detalhe da pesquisa
1.
Safety and efficacy of sofosbuvir-velpatasvir-voxilaprevir for re-treatment of chronic hepatitis C virus infection in patients with previous direct-acting antiviral treatment failure in Rwanda (SHARED-3): a single-arm trial.
Lancet Gastroenterol Hepatol
; 7(6): 542-551, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35248212
2.
Safety and efficacy of sofosbuvir-velpatasvir to treat chronic hepatitis C virus infection in treatment-naive patients in Rwanda (SHARED-3): a single-arm trial.
Lancet Gastroenterol Hepatol
; 7(6): 533-541, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35248213